TENEDINI, Elena
 Distribuzione geografica
Continente #
NA - Nord America 12.629
AS - Asia 6.509
EU - Europa 6.141
SA - Sud America 850
AF - Africa 195
OC - Oceania 58
Continente sconosciuto - Info sul continente non disponibili 15
Totale 26.397
Nazione #
US - Stati Uniti d'America 12.370
GB - Regno Unito 1.838
SG - Singapore 1.803
CN - Cina 1.575
IT - Italia 1.351
VN - Vietnam 753
HK - Hong Kong 749
BR - Brasile 604
SE - Svezia 603
DE - Germania 512
FR - Francia 346
RU - Federazione Russa 307
BD - Bangladesh 286
FI - Finlandia 269
TR - Turchia 254
KR - Corea 211
UA - Ucraina 193
IN - India 186
CA - Canada 165
ID - Indonesia 126
IE - Irlanda 101
BG - Bulgaria 84
NL - Olanda 83
JP - Giappone 73
PL - Polonia 71
AR - Argentina 68
IQ - Iraq 66
IR - Iran 65
PK - Pakistan 62
SI - Slovenia 61
ZA - Sudafrica 61
ES - Italia 58
MX - Messico 57
AU - Australia 54
BE - Belgio 48
EC - Ecuador 42
AE - Emirati Arabi Uniti 41
CL - Cile 41
CO - Colombia 41
LT - Lituania 29
CZ - Repubblica Ceca 28
SA - Arabia Saudita 28
MA - Marocco 27
TW - Taiwan 27
MY - Malesia 25
EG - Egitto 23
KE - Kenya 22
UZ - Uzbekistan 22
AT - Austria 20
VE - Venezuela 20
QA - Qatar 19
RO - Romania 18
IL - Israele 17
NP - Nepal 16
CH - Svizzera 15
NO - Norvegia 15
PT - Portogallo 15
TH - Thailandia 15
TN - Tunisia 14
HU - Ungheria 13
PH - Filippine 13
DZ - Algeria 12
AZ - Azerbaigian 11
KG - Kirghizistan 11
PE - Perù 11
MD - Moldavia 8
AL - Albania 7
BO - Bolivia 7
CI - Costa d'Avorio 7
CR - Costa Rica 7
GR - Grecia 7
MO - Macao, regione amministrativa speciale della Cina 7
RS - Serbia 7
UY - Uruguay 7
DK - Danimarca 6
EU - Europa 6
MK - Macedonia 6
MN - Mongolia 6
PY - Paraguay 6
SY - Repubblica araba siriana 6
XK - ???statistics.table.value.countryCode.XK??? 6
BH - Bahrain 5
HR - Croazia 5
KZ - Kazakistan 5
OM - Oman 5
PA - Panama 5
BY - Bielorussia 4
DO - Repubblica Dominicana 4
ET - Etiopia 4
GE - Georgia 4
GH - Ghana 4
HN - Honduras 4
IS - Islanda 4
JM - Giamaica 4
NZ - Nuova Zelanda 4
PR - Porto Rico 4
A2 - ???statistics.table.value.countryCode.A2??? 3
JO - Giordania 3
KW - Kuwait 3
NG - Nigeria 3
Totale 26.347
Città #
Southend 1.303
Ashburn 1.217
Singapore 1.135
Santa Clara 1.070
Fairfield 1.066
Hong Kong 708
Chandler 671
Woodbridge 656
San Jose 645
Houston 485
Seattle 391
Ann Arbor 385
Hefei 384
Wilmington 338
Beijing 335
Nyköping 322
Cambridge 321
Council Bluffs 299
Dearborn 298
Jacksonville 297
London 253
Chicago 250
Modena 244
Los Angeles 235
Ho Chi Minh City 221
New York 177
Hanoi 176
Seoul 176
Helsinki 166
The Dalles 142
Milan 110
Izmir 106
Dublin 97
Munich 97
Jakarta 96
Salt Lake City 96
San Diego 91
Sofia 83
Lauterbourg 82
Princeton 79
Buffalo 78
Moscow 76
Shanghai 72
Eugene 68
Dallas 67
Frankfurt am Main 65
Bologna 62
Tampa 62
Fremont 58
Elk Grove Village 57
Dong Ket 55
Orem 55
Redwood City 54
São Paulo 53
Rome 52
Bremen 45
Falls Church 44
Toronto 43
Des Moines 42
Montreal 40
Tokyo 39
Warsaw 39
Brussels 38
Turku 38
Boardman 36
Guangzhou 33
Da Nang 31
Johannesburg 30
Atlanta 28
Baghdad 28
Haiphong 28
Lancaster 28
Columbus 26
Denver 26
Florence 26
Istanbul 26
Phoenix 26
Parma 23
Sterling 23
Melbourne 22
Amsterdam 21
Miami 21
Quito 21
Santiago 20
Brooklyn 19
Las Vegas 19
Rio de Janeiro 19
Stockholm 19
Falkenstein 18
Nuremberg 18
Biên Hòa 17
Brasília 17
Brno 17
Chennai 17
Doha 17
Kent 17
Ottawa 17
Paris 17
Reggio Emilia 17
Ankara 16
Totale 17.409
Nome #
Targeted cancer exome sequencing reveals recurrent mutations in myeloproliferative neoplasms 566
A Next Generation Sequencing amplicon-based strategy to explore Inherited Retinal Degeneration complexity 551
c-Myb supports erythropoiesis through the transactivation of KLF1 and LMO2 expression. 510
c-Myb supports erythropoiesis by transactivating KLF1 and LMO2 expression 488
New modulated genes in psoriasis-derived keratinocyte subpopulations. 470
Implementation of an NGS-based workflow for BRCA1 and BRCA2 mutation screening 463
Embryonic stem-derived versus somatic neural stem cells: A comparative analysis of their developmental potential and molecular phenotype 449
The barley Frost resistance-H2 locus 444
Virally mediated MafB transduction induces the monocyte commitment of human CD34+ hematopoietic stem/progenitor cells 431
ERBB2 mutations in hormone receptor positive primary breast cancers samples and in their matched endocrine-resistant recurrences. 417
Abstracts from the 55th European Society of Human Genetics (ESHG) Conference: Hybrid Posters 406
Intrinsic phenotypic diversity of embryonic and fetal myoblasts is revealed by genome-wide gene expression analysis on purified cells 401
Gene expression profiling of normal and malignant CD34-derived megakaryocytic cells 397
ANALISYS OF GENE EXPRESSION PROFILE DURING MYOGENESIS EVIDENCES DIFFERENT MOLECULAR DEFECTS AT THE BASIS OF FSHD-1 AND FSHD-2 PATHOGENESIS 396
Unravelling the Complexity of Inherited Retinal Dystrophies Molecular Testing: Added Value of Targeted Next-Generation Sequencing 395
Eosinophils, but not neutrophils, exibit an efficient DNA repair machinary and high nucleolar activity 394
Correlation between differentiation plasticity and mRNA expression profiling of CD34+-derived CD14- and CD14+ human normal myeloid precursors 391
Transcriptional profiles in melanocytes from clinically unaffected skin distinguish the neoplastic growth pattern in patients with melanoma 379
Ceruloplasmin gene variants are associated with hyperferritinemia and increased liver iron in patients with {NAFLD} 374
Amplicon-based Next Generation Sequencing: an effective approach to molecular diagnosis of Epidermolysis Bullosa 372
Amplicon-based next-generation sequencing: an effective approach for the molecular diagnosis of epidermolysis bullosa 368
Genomic alterations at the basis of treatment resistance in metastatic breast cancer: Clinical applications 365
The kinetic status of hematopoietic stem cell subpopulations underlies a differential expression of genes involved in self-renewal, commitment, and engraftment. 364
Hereditary pancreatic cancer: A retrospective single-center study of 5143 Italian families with history of BRCA-related malignancies 362
Identification of a molecular signature predictive of sensitivity to differentiation induction in acute myeloid leukemia 352
No Identical ‘‘Mesenchymal Stem Cells’’ at Different Times and Sites: Human Committed Progenitors of Distinct Origin and Differentiation Potential Are Incorporated as Adventitial Cells in Microvessels 351
Requirement of the coiled-coil domains of p92(c-Fes) for nuclear localization in myeloid cells upon induction of differentiation 338
Impact of mutational status on outcomes in myelofibrosis patients treated with ruxolitinib in the COMFORT-II study 336
Tfe3 expression is closely associated to macrophage terminal differentiation of human hematopoietic myeloid precursors. 331
WISP-2 expression induced by Teriparatide treatment affects in vitro osteoblast differentiation and improves in vivo osteogenesis 330
Abnormal expression patterns of WT1-as, MEG3 and ANRIL long non-coding RNAs in CD34+ cells from patients with primary myelofibrosis and their clinical correlations 325
Isolation of human keratinocyte stem cells and high-throughput screening approach for their characterization 319
Gene expression profile of vitamin D3 treated HL60 cells shows an incomplete molecular phenotypic conversion to monocytes 318
Gene expression profiles of human granulosa cells treated with bioequivalent doses of corifollitropin alfa (CFA) or recombinant human follicle-stimulating hormone (recFSH) 317
Integrated analysis of microRNA and mRNA expression profiles in physiological myelopoiesis: role of hsa-mir-299-5p in CD34+ progenitor cells commitment 316
Identification of a molecular signature for leukemic promyelocytes and their normal counterparts: focus on DNA repair genes 307
Brca detection rate in an italian cohort of luminal early-onset and triple-negative breast cancer patients without family history: When biology overcomes genealogy 307
Impact Of Prognostically Detrimental Mutations (ASXL1, EZH2, SRSF2, IDH1/2) On Outcomes In Patients With Myelofibrosis Treated With Ruxolitinib In COMFORT-II 304
uPA/uPAR system activation drives a glycolytic phenotype in melanoma cells 303
HGM 2010 Programme / Abstract 297
Single-keratinocyte transcriptomic analyses identify different clonal types and proliferative potential mediated by FOXM1 in human epidermal stem cells 293
DIAGNOSI MOLECOLARE DELLE IPERTRIGLICERIDEMIE PRIMITIVE ATTRAVERSO “NGS” (NEXT GENERATION SEQUENCING) 291
IDENTIFICATION OF A MOLECULAR SIGNATURE PREDICTIVE OF REFRACTORINESS IN ACUTE MYELOID LEUKEMIA 291
Identification of new p63 targets in human keratinocytes 290
Integrated analysis of microRNA and mRNA expression profiles in physiological myelopoieis: role of hsa-miR-299-5p in CD34+ progenitor cells commitment 286
Development of an IL-6 antagonist peptide that induces apoptosis in IL-6 dependent 7TD1 cells. 286
Clinicopathologic Profile of Breast Cancer in Germline ATM and CHEK2 Mutation Carriers 284
AMPLICON-BASED NGS: AN EFFECTIVE APPROACH FOR THE MOLECULAR DIAGNOSIS OF EPIDERMOLYSIS BULLOSA 283
IDENTIFICATION OF A MOLECULAR SIGNATURE PREDICTIVE OF REFRACTORINESS IN ACUTE MYELOID LEUKEMIA 276
STRATEGIES TO PREDICT TREATMENT RESPONSE AND SELECT THERAPIES IN METASTATIC BREAST CANCER PATIENTS USING A NEXT GENERATION SEQUENCING (NGS) MULTI-GENE PANEL 275
Expression profiling of FSHD-1 and FSHD-2 cells during myogenic differentiation evidences common and distinctive gene dysregulation patterns 273
Identification of miR-31-5p, miR-141-3p, miR-200c-3p, and GLT1 as human liver aging markers sensitive to donor-recipient age-mismatch in transplants 269
Chromosome 9p trisomy increases stem cells clonogenic potential and fosters T-cell exhaustion in JAK2-mutant myeloproliferative neoplasms 261
Integrated analysis of microRNA and mRNA expression profiles in physiological myelopoieis: role of hsa-mir-299-5p in CD34+ progenitor cells commitment 261
MOLECULAR REGULATION OF STEROL METABOLISM BY BILE ACIDS IN CULTURED HUMAN HEPATOCYTES 259
Osteocytes signaling events induced by intermittent vs continuous Teriparatide treatment affect in vitro osteoblast differentiation and mineralization 252
Abnormal expression of WT1-as, MEG3 and ANRIL long non-coding RNAs in primary myelofibrosis and their clinical correlates 249
STRATEGIES TO PREDICT TREATMENT RESPONSE AND SELECT THERAPIES IN METASTATIC BREAST CANCER PATIENTS USING A NEXT GENERATION SEQUENCING MULTI-GENE PANEL 249
CXCR3 identifies human naive CD8+ T cells with enhanced effector differentiation potential 249
Wisp2 overexpression induced by short Teriparatide treatment affects IDG-SW3 osteogenic differentiation. 246
MICAL2 is expressed in cancer associated neo-angiogenic capillary endothelia and it is required for endothelial cell viability, motility and VEGF response 242
The early expansion of anergic NKG2Apos/CD56dim/CD16neg natural killer represents a therapeutic target in haploidentical hematopoietic stem cell transplantation 241
Characterization of new ATM deletion associated with hereditary breast cancer 241
Chromosome 9p Duplication Promotes T-Cell Exhaustion and Enhances Stem Cell Clonogenic Potential in JAK2-Mutant Myeloproliferative Neoplasms 239
Workload measurement for molecular genetics laboratory: A survey study 234
Clinical application of NGS in the diagnosis of iron overload disorders or hyperferritinemia of genetic origin 231
Automated capture-based NGS workflow: one thousand patients experience in a clinical routine framework 226
Physiological levels of 1 alpha, 25 di-hydroxyvitamin D3 induce the monocytic commitment of CD34+ hematopoietic progenitors 221
Gene Expression profile of Vitamin D3 treated HL60 cells shows a phenotypic but not a complete functional conversion to monocytes 219
The chaperone activity of 4PBA ameliorates the skeletal phenotype of Chihuahua, a zebrafish model for dominant osteogenesis imperfecta 218
Tie2 expressing monocytes in the spleen of patients with primary myelofibrosis 212
Survival features of EBV-stabilized cells from centenarians: morpho-functional and transcriptomic analyses. 209
Gene expression Profile of Human Myeloid Cells 206
Liver Aging in Transplantation: Future Perspective on Donor-Recipient Age-Mismatch 205
Ivar, an interpretation‐oriented tool to manage the update and revision of variant annotation and classification 205
P2X7 receptor activity limits accumulation of T cells within tumors 198
Management of PALB2-associated breast cancer: A literature review and case report 193
Constitutional Mosaicism: A Critical Issue in the Definition of BRCA-Inherited Cancer Risk 188
Requirement of the coiled coil domains of p92c-Fes for nuclear translocation in myeloid cells upon induction of differentiation 177
Targeting exhausted cytotoxic T cells through CTLA‐4 inhibition promotes elimination of neoplastic cells in human myelofibrosis xenografts 170
Pre-existing cytopenia heralding de novo acute myeloid leukemia: Uncommon presentation of NPM1-mutated AML in a single-center study 163
LOW-FREQUENCY ALLELE VARIANTS IN NGS MULTI-GENE PANELS FOR HEREDITARY CANCER TESTING: ARTIFACTS, CHIP OR MOSAICS? MANAGING THE RESULTS IN THE LABORATORY ROUTINE 159
Automation of a capture-based NGS workflow: one thousand patients experience in a diagnostic clinical routine framework 157
Clinically relevant low-frequency Next Generation Sequencing variants in hereditary cancer patients: an operational multi-step algorithm for laboratory managing 154
Integrated analysis of microRNA and mRNA expression profiles in physiological myelopoieis: role of hsa-mir- 299-5p in CD34+ progenitor cells commitment 149
Detection of germline variants in 450 breast/ovarian cancer families with a multi‐gene panel including coding and regulatory regions 149
The prognostic and predictive role of somatic brca mutations in ovarian cancer: Results from a multicenter cohort study 136
Homologous recombination deficiency in pancreatic neuroendocrine tumors 133
Reduced reproductive potential in young healthy women with hereditary breast and/or ovarian cancer syndrome 123
Characterization of copy number variants in hereditary cancer patients through NGS shows a distinctive PALB2 contribution to the diagnostic yield 97
Diagnostic Yield and Clinical Impact of a Small Genetic Panel for Kidney Disease: A Multicenter, Retrospective European Study 94
Real-world effectiveness of PARP inhibitors after CDK4/6 inhibitor therapy in BRCA-mutated HR-positive/HER2-negative advanced breast cancer 27
BRCA Detection Rate in an Italian Cohort of Luminal Early-Onset and Triple-Negative Breast Cancer Patients without Family History: When Biology Overcomes Genealogy. Cancers 2020 20
ASSOCIATION BETWEEN TYPE AND LOCATION OF GERMLINE BRCA1/2 PATHOGENIC OR LIKELY PATHOGENIC VARIANTS WITH PHENOTYPE AND PROGNOSIS IN YOUNG PATIENTS WITH BREAST CANCER: RESULTS FROM AN INTERNATIONAL COHORT STUDY. 17
Clinical outcome and proportion of hereditary cancer genes gPV in TNBC: the HEaRTBeat study. 15
Impaired glucose tolerance in women with BRCA1 versus BRCA2 pathogenic or likely pathogenic variants: Results from a prospective cohort study 9
Totale 26.604
Categoria #
all - tutte 93.822
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 93.822


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021233 0 0 0 0 0 0 0 0 0 0 0 233
2021/20221.859 120 192 197 102 80 135 107 75 166 179 302 204
2022/20232.167 252 261 233 213 195 269 43 198 299 18 105 81
2023/20241.505 45 82 105 132 214 142 230 190 32 49 99 185
2024/20254.750 159 72 117 264 882 699 365 327 450 259 556 600
2025/20269.102 606 363 603 955 1.556 613 1.184 459 855 845 667 396
Totale 26.604